Handelsbanken Fonder AB Has $133.49 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Handelsbanken Fonder AB lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 32.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 255,743 shares of the medical equipment provider's stock after purchasing an additional 63,201 shares during the period. Handelsbanken Fonder AB owned 0.07% of Intuitive Surgical worth $133,488,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Howard Capital Management Group LLC increased its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock valued at $1,044,000 after buying an additional 92 shares in the last quarter. Ledyard National Bank acquired a new position in Intuitive Surgical in the third quarter valued at about $214,000. Foundations Investment Advisors LLC increased its holdings in shares of Intuitive Surgical by 8.5% in the third quarter. Foundations Investment Advisors LLC now owns 590 shares of the medical equipment provider's stock worth $290,000 after acquiring an additional 46 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 4.2% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 7,618 shares of the medical equipment provider's stock valued at $3,742,000 after purchasing an additional 308 shares in the last quarter. Finally, Eastern Bank grew its position in shares of Intuitive Surgical by 81.4% in the 3rd quarter. Eastern Bank now owns 4,063 shares of the medical equipment provider's stock valued at $1,996,000 after purchasing an additional 1,823 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last ninety days. Insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Down 2.4 %

Shares of NASDAQ ISRG traded down $14.78 during midday trading on Friday, hitting $591.79. 1,673,828 shares of the company's stock were exchanged, compared to its average volume of 1,567,754. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company's 50 day moving average price is $565.45 and its 200 day moving average price is $525.06. The firm has a market capitalization of $210.78 billion, a PE ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Finally, Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.